Dr. Eva Feldman to address Michigan Israel Business Bridge Nov. 12 in Grand Rapids
Taubman Institute Director Dr. Eva Feldman will address a special event at the Van Andel Institute in Grand Rapids on Monday, Nov. 12. The meeting is a special networking luncheon with the Michigan Israel Business Bridge, a non-profit association that promotes economic growth in Michigan and Israel.
Dr. Feldman, the Russell N. DeJong professor of neurology at the University of Michigan and leader of the first-ever stem cell trial in patients with ALS, will tell the groups about her groundbreaking collaboration with another stem cell pioneer, Benjamin E. Reubinoff, M.D., Ph.D., of Hadassah University Hospital in Jerusalem. Her talk is entitled "U-M and Hadassah: Engineering stem cells to decode a deadly disease."
The luncheon will take place from noon to 1:30 p.m.; registration is required by Nov. 6. The charge for MIBB members is $30 or $35 for non-members. For complete details, click here.
Stem cell symposium set for Sept. 19 in Ann Arbor
Dr. Eva Feldman will be among the speakers at the one-day event, which focuses on cutting-edge developments in stem-cell biology, epigenetics and regneratrive medicine.
Click here for details and registration.
New Emerging Scholar named
Scott Tomlins, M.D., an assistant profesor of pathology at U-M, has been designated the A. Alfred Taubman Emerging Scholar. Dr. Tomlins is an expert in prostate cancer research.
People who care
Institute welcomes new gift officer
Maria Muller has been appointed to work with connect donors with funding opportunities at the Taubman Institute.
Click here to read more.
news & events
Institute symposium set for Oct. 10
The A. Alfred Taubman Medical Research Institute will award the 2014 $100,000 Taubman Prize for Excellence in Translational Medical Science at its 7th annual symposium at 10 a.m. on Oct. 10.
Dr. Carl June, a physician-scientist who developed a personalized immunotherapy for leukemia using patients’ own T cells, will receive the honor and deliver the symposium's keynote address.
Click here for symposium details.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.